Gram-negative bacterial sepsis is a medical catastrophe, claiming the lives of 35-40 percent of affected patients. There has been little progress in improving the poor outcome of sepsis, due to our inadequate understanding of the basic pathophysiology of the syndrome. Sepsis results from a cascade of life-threatening host responses beginning with the interaction of bacterial lipopolysaccharide (LPS) and the LPS-receptor complex on effector cells. CD14 appears to be the LPS-binding component of this complex. The exact components of the complex, and the mechanism of signal transduction, are uncertain. Two Toll-like receptors (TLRs), TLR2 and TLR4, function as LPS signal transducers. Expression of TLR4, but not TLR2, is obligatory for sensitive responses to LPS. TLR2 functions as a pattern recognition molecule for bacterial products (including LPS) from multiple types of bacteria. LPS-receptor specificity resides in TLR4: expression of TLR4 defines a highly specific pharmacology to lipid A and its analogs. The central hypothesis of this proposal is that LPS is recognized by a multimeric receptor consisting of CD14 and of a complex of TLRs and accessory molecules. TLR4 is the predominant LPS receptor in most cells; TLR2 may be important for sCD14/LPS recognition. Upon ligand binding, TLRs multimerize and engage signaling molecules similar or identical to those used by the IL-1 receptor. LPS antagonists may function by preventing TLR multimerization. We propose three Aims to test this hypothesis. 1. To analyze available known TLRs (including TLRs 1, 3, 5, 6 and 7) and chimeric TLR constructs as potential LPS receptor components. To identify regions of TLR4 that are necessary for specific ligand recognition. To determine if epitope-tagged TLRs multimerize, and if multimerization is inhibited by LPS antagonists. 2. To use [32P]-lipid IVa to analyze lipid A binding to TLRs, especially TLR4. 3. To identify new genes in the LPS signal transduction pathway using somatic cell mutagenesis and complementation analysis approaches. The discovery of Toll-like receptors as mediators of signal transduction for both Gram-positive and Gram-negative bacteria suggests that there are common signaling elements that can be discovered and targeted for the rational design of novel therapeutic agents for sepsis, an thus reduce the appalling morbidity and mortality associated with this disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM054060-05
Application #
6386312
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Program Officer
Somers, Scott D
Project Start
1999-01-01
Project End
2001-06-30
Budget Start
2001-04-01
Budget End
2001-06-30
Support Year
5
Fiscal Year
2001
Total Cost
$151,861
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
Tzeng, Te-Chen; Schattgen, Stefan; Monks, Brian et al. (2016) A Fluorescent Reporter Mouse for Inflammasome Assembly Demonstrates an Important Role for Cell-Bound and Free ASC Specks during In Vivo Infection. Cell Rep 16:571-582
Heneka, Michael T; Kummer, Markus P; Stutz, Andrea et al. (2013) NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493:674-8
Levitz, Stuart M; Golenbock, Douglas T (2012) Beyond empiricism: informing vaccine development through innate immunity research. Cell 148:1284-92
Nagpal, Kamalpreet; Plantinga, Theo S; Sirois, Cherilyn M et al. (2011) Natural loss-of-function mutation of myeloid differentiation protein 88 disrupts its ability to form Myddosomes. J Biol Chem 286:11875-82
Caetano, Braulia C; Carmo, Bianca B; Melo, Mariane B et al. (2011) Requirement of UNC93B1 reveals a critical role for TLR7 in host resistance to primary infection with Trypanosoma cruzi. J Immunol 187:1903-11
Meng, Jianmin; Lien, Egil; Golenbock, Douglas T (2010) MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation. J Biol Chem 285:8695-702
Lysakova-Devine, Tatyana; Keogh, Brian; Harrington, Barry et al. (2010) Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule. J Immunol 185:4261-71
Melo, Mariane B; Kasperkovitz, Pia; Cerny, Anna et al. (2010) UNC93B1 mediates host resistance to infection with Toxoplasma gondii. PLoS Pathog 6:e1001071
Seimon, Tracie A; Nadolski, Marissa J; Liao, Xianghai et al. (2010) Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab 12:467-82
Meng, Jianmin; Drolet, Joshua R; Monks, Brian G et al. (2010) MD-2 residues tyrosine 42, arginine 69, aspartic acid 122, and leucine 125 provide species specificity for lipid IVA. J Biol Chem 285:27935-43

Showing the most recent 10 out of 89 publications